Gemtaz Infusmart 1.4gm Injection is a vital medication used in the treatment of various cancers. Its active ingredient, Gemcitabine, is a nucleoside analog that works by interfering with DNA synthesis and repair, ultimately leading to the death of cancer cells. This makes it an effective chemotherapeutic agent against a range of malignancies.
Gemtaz Infusmart is indicated for the treatment of pancreatic cancer, non-small cell lung cancer, breast cancer, and ovarian cancer. The dosage and administration of Gemtaz Infusmart 1.4gm Injection should be strictly determined by a qualified healthcare professional, considering the specific type and stage of cancer, as well as the patient’s overall health condition. It is typically administered intravenously.
Common side effects associated with Gemtaz Infusmart may include fatigue, nausea, vomiting, fever, hair loss, and a decrease in blood cell counts (anemia, neutropenia, thrombocytopenia). Patients may also experience flu-like symptoms. It is crucial to report any unusual or severe side effects to your doctor immediately.
Gemtaz Infusmart 1.4gm Injection should be stored at room temperature (20°C to 25°C or 68°F to 77°F) and protected from light. It should not be frozen. Always follow your healthcare provider’s instructions regarding storage and disposal.
